FDA Adverse Event Summary report: N

BD BBL PORT-A-CUL ENVELOPE

MDR report key: 2398835 · Received December 21, 2011

Report

Report Number
2398835
Date Received
December 21, 2011
Date of Event
December 17, 2011
Report Date
December 21, 2011
Manufacturer
BECTON, DICKINSON AND COMPANY
Product Code
JTX
Report Source
User Facility report
Reporter Location
CA, US
Reporter Occupation
RISK MANAGER

Narratives

Description of Event or Problem · 1

THE MICROBIOLOGY LAB HAD FOLLOWED UP ON A CONFUSING ARTIFACT SEEN IN THE BECTON DICKINSON (BD) BBL PORT-A-CUL ANAEROBIC TRANSPORT MEDIA. IT LOOKED LIKE A GRAM VARIABLE ROD BUT WAS NON-VIABLE. AT THE TIME DECISION WAS MADE TO IN-SERVICE THE LAB STAFF TO RECOGNIZE THE ARTIFACT SO IT WOULD NOT BE REPORTED AS AN ORGANISM. SINCE THE ORGANISM WAS NON-VIABLE, AND THERE WAS NO DANGER OF THE LAB WORKING IT UP ON THE CULTURE, THE DECISION MADE TO EDUCATE STAFF NOT TO REPORT THESE ARTIFACTS ON THE GRAM STAIN WE COULD CONTINUE TO USE THEM UNTIL A REPLACEMENT PRODUCT WAS FOUND. IN-SERVICING AND RELATED E-MAIL TOOK PLACE BUT THE EDUCATION PROCESS FAILED AS A RESULT OF THE SURGERY AND THE REPORT OF RARE GRAM NEG RODS. A SURGERY TOOK PLACE AND A STAT GRAM NEG SPECIMEN SENT TO THE LAB. THE RESULTS WERE INCONCLUSIVE. FINDINGS WERE OF RARE GRAM NEGATIVE RODS. A TISSUE SAMPLE WAS THEN SENT RATHER THAN SWAB. THE CULTURE MEDIUM WAS CULTURED AND GRAM NEGATIVE RODS WERE FOUND.THE LAB CONTACTED BD TECHNICAL SERVICE AND INFORMED THE PACKAGE INSERT FOR THE PRODUCT STATES: TRANSPORT MEDIA SOMETIMES CONTAIN DEAD ORGANISMS VISIBLE UPON GRAM STAINING. SCRIPPS HAS REQUESTED AN INTERNAL RECALL OF THIS PRODUCT AND REMOVE IT FROM ALL SITES.======================MANUFACTURER RESPONSE FOR ANAEROBIC TRANSPORT MEDIA, BD BBL PORT-A-CUL ENVELOPE (PER SITE REPORTER).======================INSTRUCTED TO REVIEW PACKAGE INSERT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BD BBL PORT-A-CUL ENVELOPE ANAEROBIC TRANSPORT MEDIA JTX BECTON, DICKINSON AND COMPANY 221607 1168822 LANE 5

Patients

Seq Age Sex Outcome Treatment
1 49 YR